In 2004, two Boston-based academic groups discovered EGFR mutations in NSCLC, one through a systematic kinome-directed sequencing approach (Paez et al, 2004), and the second thanks to a hypothesis-driven EGFR sequencing effort (Lynch et al, 2004). Here, EGFR is linked to non-small cell lung carcinoma.